Literature DB >> 25550977

Two-staged stent-assisted angioplasty treatment strategy for severe left main coronary distal bifurcation stenosis associated with the right coronary chronic total occlusion.

Yong-Yao Yang1, Qiang Wu1.   

Abstract

A 63-year-old female patient, with history of 8-year hypertension and 10-year hyperlipidemia, presented with severe left main coronary bifurcation stenosis (LMCS) associated with the right coronary artery chronic total occlusion (CTO-RCA). On the day of admission, she received drug treatment with aspirin, clopidogrel, heparin, statins, angiotensin converting enzyme inhibitors and β-blocker. On the next day, she underwent CTO recanalization with 6F guiding-catheter and two rapamycin-eluting stents, and showed no postoperative discomfort after interventional treatment. Considering having hypertensive nephropathy and chronic renal insufficiency, the patient then received intravenous saline full hydration therapy. Two weeks after successful completion of the RCA revascularization, the original collateral circulation in the blood flow from the LMC to RCA became two-way flow. Under the safe and reliable protective condition, staged percutaneous coronary intervention (PCI) with 6F XB3.0 guiding catheter and rapamycin-eluting stents was applied to treat the LMCL. 9-month postoperative follow-up with coronary computed tomographic imaging showed no restenosis inside the original stent, without any myocardial ischemic event. Our successful approach to turn the original unprotected LMCS combined with CTO-RCA into a protective one reduces the interventional risk and provides additional option besides coronary artery bypass graft surgery to treat such complex coronary artery disease (CAD).

Entities:  

Keywords:  Left main coronary artery stenosis; angiography; percutaneous coronary intervention; the right coronary artery chronic total occlusion

Year:  2014        PMID: 25550977      PMCID: PMC4276235     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  8 in total

1.  2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions.

Authors:  Glenn N Levine; Eric R Bates; James C Blankenship; Steven R Bailey; John A Bittl; Bojan Cercek; Charles E Chambers; Stephen G Ellis; Robert A Guyton; Steven M Hollenberg; Umesh N Khot; Richard A Lange; Laura Mauri; Roxana Mehran; Issam D Moussa; Debabrata Mukherjee; Brahmajee K Nallamothu; Henry H Ting
Journal:  J Am Coll Cardiol       Date:  2011-11-07       Impact factor: 24.094

2.  Timing of staged percutaneous coronary intervention in multivessel coronary artery disease.

Authors:  George D Dangas; Jon C George; William Weintraub; Jeffrey J Popma
Journal:  JACC Cardiovasc Interv       Date:  2010-10       Impact factor: 11.195

3.  Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for ostial/midshaft lesions in unprotected left main coronary artery from the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.

Authors:  Toru Naganuma; Alaide Chieffo; Emanuele Meliga; Davide Capodanno; Seung-Jung Park; Yoshinobu Onuma; Marco Valgimigli; Sanda Jegere; Raj R Makkar; Igor F Palacios; Charis Costopoulos; Young-Hak Kim; Piotr P Buszman; Tarun Chakravarty; Imad Sheiban; Roxana Mehran; Christoph Naber; Ronan Margey; Arvind Agnihotri; Sebastiano Marra; Piera Capranzano; Martin B Leon; Jeffrey W Moses; Jean Fajadet; Thierry Lefevre; Marie-Claude Morice; Andrejs Erglis; Corrado Tamburino; Ottavio Alfieri; Patrick W Serruys; Antonio Colombo
Journal:  JACC Cardiovasc Interv       Date:  2014-03-14       Impact factor: 11.195

4.  Contemporary percutaneous treatment of unprotected left main coronary stenoses: initial results from a multicenter registry analysis 1994-1996.

Authors:  S G Ellis; H Tamai; M Nobuyoshi; K Kosuga; A Colombo; D R Holmes; C Macaya; C L Grines; P L Whitlow; H J White; J Moses; P S Teirstein; P W Serruys; J A Bittl; M R Mooney; T M Shimshak; P C Block; R Erbel
Journal:  Circulation       Date:  1997-12-02       Impact factor: 29.690

5.  Comparison of double kissing crush versus Culotte stenting for unprotected distal left main bifurcation lesions: results from a multicenter, randomized, prospective DKCRUSH-III study.

Authors:  Shao-Liang Chen; Bo Xu; Ya-Ling Han; Imad Sheiban; Jun-Jie Zhang; Fei Ye; Tak W Kwan; Chitprapai Paiboon; Yu-Jie Zhou; Shu-Zheng Lv; George D Dangas; Ya-Wei Xu; Shang-Yu Wen; Lang Hong; Rui-Yan Zhang; Hai-Chang Wang; Tie-Ming Jiang; Yan Wang; Fang Chen; Zu-Yi Yuan; Wei-Min Li; Martin B Leon
Journal:  J Am Coll Cardiol       Date:  2013-03-10       Impact factor: 24.094

Review 6.  Update on acute coronary syndromes: the pathologists' view.

Authors:  Erling Falk; Masataka Nakano; Jacob Fog Bentzon; Aloke V Finn; Renu Virmani
Journal:  Eur Heart J       Date:  2012-12-13       Impact factor: 29.983

7.  Crush, culotte, T and protrusion: which 2-stent technique for treatment of true bifurcation lesions? - insights from in vitro experiments and micro-computed tomography.

Authors:  Nicolas Foin; Eduardo Alegria-Barrero; Ryo Torii; Pak H Chan; N Viceconte; Justin E Davies; Carlo Di Mario
Journal:  Circ J       Date:  2012-09-25       Impact factor: 2.993

8.  Culotte versus T-stenting in bifurcation lesions: immediate clinical and angiographic results and midterm clinical follow-up.

Authors:  Sahin Kaplan; Peter Barlis; Konstantinos Dimopoulos; Alessio La Manna; Omer Goktekin; Alfredo Galassi; Jun Tanigawa; Carlo Di Mario
Journal:  Am Heart J       Date:  2007-08       Impact factor: 4.749

  8 in total
  1 in total

1.  Percutaneous coronary intervention for ostial lesions of the left main stem in a patient with congenital single left coronary artery: A case report.

Authors:  Qiang Wu; Zong-Zhuang Li; Feng Yue; Fang Wei; Chen-Yun Zhang
Journal:  World J Clin Cases       Date:  2019-08-06       Impact factor: 1.337

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.